Page last updated: 2024-12-07
hexahydrodifenidol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
hexahydrodifenidol: muscarinic antagonist; RN from Toxlit [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 124226 |
MeSH ID | M0168511 |
Synonyms (13)
Synonym |
---|
gtpl322 |
L023948 |
hexahydrodifenidol |
1-cyclohexyl-1-phenyl-4-piperidin-1-ylbutan-1-ol |
cas_113010-69-8 |
bdbm81960 |
hexahydrodiphenidol |
hexahydro-diphenidol |
113010-69-8 |
piperidinebutanol, alpha-cyclohexyl-alpha-phenyl- |
1-cyclohexyl-1-phenyl-4-(piperidin-1-yl)butan-1-ol |
DTXSID60920977 |
Q27077979 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (5)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1345343 | Human M3 receptor (Acetylcholine receptors (muscarinic)) | 1989 | Molecular pharmacology, Apr, Volume: 35, Issue:4 | Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. |
AID1345543 | Human M5 receptor (Acetylcholine receptors (muscarinic)) | 1989 | Molecular pharmacology, Apr, Volume: 35, Issue:4 | Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. |
AID1345326 | Human M2 receptor (Acetylcholine receptors (muscarinic)) | 1989 | Molecular pharmacology, Apr, Volume: 35, Issue:4 | Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. |
AID1345189 | Rat M1 receptor (Acetylcholine receptors (muscarinic)) | 1989 | Molecular pharmacology, Apr, Volume: 35, Issue:4 | Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. |
AID1345465 | Human M4 receptor (Acetylcholine receptors (muscarinic)) | 1989 | Molecular pharmacology, Apr, Volume: 35, Issue:4 | Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (10)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (50.00) | 18.7374 |
1990's | 5 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.96
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.96) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (9.09%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 10 (90.91%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |